Efficacy and safety of continuous veno-venous hemofiltration for acute respiratory distress syndrome: a meta-analysis
Frontiers in Medicine · 17.07.2026 · 13
DOI: 10.3389/fmed.2026.1856590 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Medicine, online erschienen am 17.07.2026. Verfasst von Rui Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Xinjiang Medical University, Urumqi, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
To evaluate the efficacy and safety of continuous veno-venous hemofiltration (CVVH) in patients with acute respiratory distress syndrome (ARDS) using a meta-analytic approach.
Methods
Randomized controlled trials on CVVH for ARDS were retrieved from Chinese databases (Wanfang, CNKI) as well as PubMed and Web of Science. Meta-analysis was performed using Review Manager 5.3 software on the extracted data.
Results
This meta-analysis included a total of 28 randomized controlled trials (RCTs) involving 1,739 patients with ARDS, comprising 897 cases in the CVVH group and 842 cases in the conventional treatment group. The results demonstrated that the CVVH group exhibited superior outcomes compared to the conventional treatment group in terms of oxygenation index (MD = 52.80, 95% CI [39.75, 65.84], p < 0.00001), mortality rate (OR = 0.43, 95% CI [0.34, 0.56], p < 0.00001), ICU hospitalization duration (MD = −4.88, 95% CI [−6.45, −3.31], p < 0.00001), mechanical ventilation duration (MD = −4.10, 95% CI [−5.04, −3.15], p < 0.00001), APACHE II score (MD = −3.62, 95% CI [−4.30, −2.95], p < 0.00001), VAP incidence (OR = 0.21, 95% CI [0.12, 0.36], p < 0.00001), PaO₂ (MD = 7.49, 95% CI [5.31, 9.67], p < 0.00001), PEEP (MD = −2.07, 95% CI [−2.85, −1.29], p < 0.00001), TNF- α (MD = −19.17, 95% CI [−27.77, −10.56], p < 0.0001), IL-6 (MD = −24.86, 95% CI [−31.88, −17.84], p < 0.00001), CRP (MD = −23.48, 95% CI [−39.96, −7.00], p = 0.005), PCT (MD = −2.31, 95% CI [−3.78, −0.84], p = 0.002), WBC (MD = −3.36, 95% CI [−6.30, −0.42], p = 0.03), MAP (MD = 3.57, 95% CI [0.55, 6.58], p = 0.02), HR (MD = −11.72, 95% CI [−14.07, −9.38], p < 0.00001), and EVLWI (MD = −2.61, 95% CI [−4.60, −0.62], p < 0.00001). No statistically significant differences were observed between the two groups regarding PaCO₂ (MD = −3.05, 95% CI [−7.12, 1.02], p = 0.14) or cardiac index (CI) (MD = 0.36, 95% CI [−0.89, 1.60], p = 0.57).
Conclusion
In conclusion, CVVH as an adjunctive therapy for ARDS improves oxygenation, reduces mortality, shortens ICU and ventilator days, lowers APACHE II score and heart rate, decreases VAP incidence, and exerts anti-inflammatory and fluid-removing effects. Although substantial heterogeneity and potential publication bias exist (e.g., for oxygenation index and mechanical ventilation duration), and all included studies are from China, CVVH demonstrates promising clinical value. Large-scale, multicenter RCTs are needed to confirm these findings and optimize treatment protocols.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Xinjiang Medical University, Urumqi, China.
- The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Zitieren
APA
Wang, R., & Xu, S. (2026). Efficacy and safety of continuous veno-venous hemofiltration for acute respiratory distress syndrome: a meta-analysis. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1856590
Vancouver
Wang R, Xu S. Efficacy and safety of continuous veno-venous hemofiltration for acute respiratory distress syndrome: a meta-analysis. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1856590
BibTeX
@article{Wang2026,
author = {Wang, Rui and Xu, Sicheng},
title = {Efficacy and safety of continuous veno-venous hemofiltration for acute respiratory distress syndrome: a meta-analysis},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1856590}
}
EUVIMED